Your position:  Homepage » For Companies » Supply Shortages


Supply shortages

BfArM makes information on reported supply shortages available to the public. This information comes directly from the pharmaceutical entrepreneur and is supplemented by data from the Medicinal Product and Application Database (AmAnDa).

This database is updated automatically on the basis of the information reported. As a rule, the BfArM will have no further information on the supply status of the medicinal products listed.

The information supplied is within the sole responsibility of the respective marketing authorisation holders. Should you have further inquiries concerning reported supply bottlenecks, we therefore recommended that you contact the pharmaceutical entrepreneur directly at the telephone number or e-mail address provided for contact.

Please note

Due to technical maintenance work our web applications will not be accessible on Friday, 02 June 2023 between 16:00 and approx. 22:00.
We apologize for any inconveniences caused.


Access and user authorisation

There is a role-based, central authentication and registration for the access to applications. The roles differentiate between the administrator in the higher federal authorities and the main user(representative) in a company or an authority. Other users are created and administrated by the representative.

In addition to customer data a X.509-certificate is needed for a first registration. This ensures sufficient safety for authentication and authorization.

More information about the certificate, request access authorization and user administration can be found in the user manuals below.

Last modified: 5/23/23

Your position:  Homepage » For Companies » Supply Shortages

This website uses session cookies to ensure login to closed areas. In order to optimize the website, we use the analysis tool Matomo. Our Matomo installation works without tracking cookies. You will find more detailed information and the possibilities to object to the use of Matomo in our data privacy declaration.